Thu, May 28, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

PIPE investors look to healthcare, biotech and financial services for opportunity

Wednesday, September 30, 2009

From Kirsten Bischoff, Opalesque New York:

Private investments in public equity (PIPE) managers expect to maintain the level at which they are currently investing in, or increase their investment activity over the next 12 to 18 months, according to a new survey by Kramer Levin Naftalis & Frankel LLP and Rodman & Renshaw LLC, and released by MergerMarket.

The firms, which surveyed US PIPE investors including private equity managers, venture capital investors, hedge fund managers and mutual fund investors, will also look overwhelmingly towards the lower mid-market range for opportunities. Over half of all the respondents expect PIPE demand to see its greatest demands within the healthcare, biotechnology and life sciences industry.

"The resurgence of the biotechs is because for an extended period of time the credit markets tightened up and many of the stocks in this sector were so depressed that even if they could get PIPE financing they didn't want it," Reid Drescher, Founder and Portfolio Manager at New York-based Cape One Financial which manages a PIPE hedge fund. The return of market liquidity as well as rising market caps have brought a resurgence of transactions within this space.

In addition to rising levels of activity in the biotech sector, Drescher has also seen an incre......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Hedge funds buy swathes of foreclosed subprimes, force up rents, float rent-bonds, Hedge funds buy Actavis, Valeant. ETFs join the party, The most loved biotechs of big hedge funds, Stocks to buy ... according to hedge funds, Atlantic City bond offering attracts hedge funds as buyers, Okumus Fund Management discloses huge new Ascent Capital Group stake[more]

    Hedge funds buy swathes of foreclosed subprimes, force up rents, float rent-bonds From Boingboing.com: When a giant hedge fund is bidding on all the foreclosed houses in a poor neighborhood, living humans don't stand a chance -- but that's OK, because rapacious investors make great landl

  2. Institutions - Institutional investors turn to real estate, planes, Assets at Bostonís five biggest family nonprofits rise to $3.5bn[more]

    Institutional investors turn to real estate, planes From Joins.com: The National Pension Service and domestic emerging market specialists who did not know where to invest in a low interest rate environment are turning to other investments like the blue-chip real estate market abroad.

  3. Regulatory - Hedge funds face tax as Iceland poised to end capital controls, Comment: Why alternatives need more transparency, not enforcement[more]

    Hedge funds face tax as Iceland poised to end capital controls From Bloomberg.com: Hedge funds and other investors who bought claims against Icelandís failed banks face a tax that targets the lendersí estates as the government prepares to unveil its plan for exiting capital controls in t

  4. Opalesque Exclusive: BMO launches multi-strat '40 act fund[more]

    Bailey McCann, Opalesque New York: As we reach new market highs, investors are looking for a way to diversify and protect their portfolios from a potential market correction. Liquid alternatives are rapidly gaining ground as a critical tool for investors to use to mitigate downside risk. The BMO

  5. All hedge fund strategies rebounded last week as market conditions normalize[more]

    Komfie Manalo, Opalesque Asia: After a difficult start this month, all hedge fund strategies ended last week in positive territory, as the Lyxor Hedge Fund Index gained 0.9% (-0.2% MTD, 3.3% YTD). According to Lyxor AMís latest Weekly Briefing, in t

 

banner